NCI federally funded research and development center (ffrdc) contract - FY19 facilities to a

Ended Awarded Last action

Contract number
75N91019F00141
Awardee
Awarding agency
Obligated
$20,958,273

Award facts

Opportunity
  • NCIOSFM190011 Solicitation number
Contract value 100% obligated
$20,958,273.07 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00023 · FY26 UDO initiative -$44
Terminate for Convenience P00024 -$954,409
Terminate for Convenience P00008 · EOI::implementing the presidents department of government efficiency cost efficiency initiative (march 19, 2025)::EOI $0
Other Administrative Action P00022 $0
Other Administrative Action P00021 $0
Supplemental Agreement for work within scope P00020 $29,561
Supplemental Agreement for work within scope P00019 $0
Supplemental Agreement for work within scope P00018 $0
Other Administrative Action P00017 $11,793
Other Administrative Action P00016 $0
Other Administrative Action P00015 $51,243
Other Administrative Action P00014 $0
Other Administrative Action P00013 $0
Change Order P00012 $0
Other Administrative Action P00011 $33,992
Change Order P00010 $50,011
Change Order P00009 $154,010
Other Administrative Action P00007 $2,691,890
Other Administrative Action P00006 $256,374
Other Administrative Action P00005 $1,226,291
Other Administrative Action P00004 $844,896
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $666,842
Original award $15,895,823
Show all 25

About this award

Written by GovTribe AI ·

The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 28, 2019, with a ceiling value of $20.96 million and an ultimate completion date of August 29, 2025. This is a child delivery order against the NCI Federally Funded Research and Development Center (FFRDC) contract, supporting FY26 facilities initiatives under cost-plus-fixed-fee pricing.

Place of performance is Frederick, Maryland. Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., serves as the NCI's FFRDC contractor, delivering biomedical research and facilities support services.

Service Contract Inventory reporting shows declining labor engagement across the performance period. FY2021 invoiced $10.6 million across 5.4 FTEs and 11,216 contractor hours at a derived rate of $947.41 per hour. FY2022 invoiced $3.7 million (4.9 FTEs, 10,235 hours, $358.87/hr). FY2023 invoiced $506 thousand (0.4 FTEs, 861 hours, $587.60/hr). FY2024, the most recent reported year, invoiced $360 thousand across 0.3 FTEs and 723 contractor hours at $498.44 per hour. Teaming depth in FY2024 remained minimal, with 1 subcontractor handling approximately 1% of contractor hours.

Quick answers

Who was awarded contract 75N91019F00141?

75N91019F00141 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 28, 2019.

How much is contract 75N91019F00141 worth?

The government has obligated $20,958,273 on 75N91019F00141.

Is contract 75N91019F00141 an order under another contract?

Yes. 75N91019F00141 is a delivery order under 75N91019D00024, an indefinite delivery contract.

Was contract 75N91019F00141 competed?

The extent of competition for 75N91019F00141 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login